Skip to main content
Glama

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. First observed

TDQS

A4.9/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, openWorldHint, idempotentHint true. Description adds specific behavior: for company type, it explains data sources (SEC EDGAR/XBRL) and handling of off-calendar fiscal years; for drug type, it lists FAERS counts, FDA approvals, trials; also notes sorting and citation URIs.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is a single paragraph but packs a lot of information. While not extremely concise, every sentence adds value. Could be slightly more structured (e.g., separate sections for company vs drug), but still efficient.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Despite no output schema, the description explicitly states return format ('paired data + pipeworx:// citation URIs per entity') and sorting behavior. Covers both entity types adequately, making the tool fully understandable.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% with descriptions for both parameters. Description adds concrete examples (tickers for company, drug names), constraints (2–5 items), and explains how each type is used, significantly augmenting the schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states 'side-by-side comparison of 2–5 companies or drugs' with multiple example queries ('compare X and Y', 'X vs Y', 'rank these companies'), clearly distinguishing it from siblings like entity_profile or resolve_entity.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicitly says 'ALWAYS PREFER over sequential single-pack lookups when comparing entities' and quantifies efficiency ('Replaces 8–15 sequential lookups'), providing clear when-to-use guidance.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.8/5.0
Disambiguation3/5

Several tools form tight clusters that are easy to confuse: ask_pipeworx/ask_pipeworx_beta/ask_pipeworx_grounded are near-identical in routing, and the six polymarket_* tools (edges, arbitrage, edge_tracker, fill_risk, kalshi_spread, bet_research) all operate on prediction markets with overlapping names and purposes. While each has a distinct job, an agent will need to read descriptions very carefully to pick the right one, especially when many are similar.

Naming Consistency2/5

Naming conventions are mixed throughout the set: many tools use verb_noun (ask_pipeworx, compare_entities, discover_tools, resolve_entity, validate_claim), but there are also noun_noun (polymarket_edges, entity_profile, bet_research), adjective_noun (deep_research, recent_alerts), and bare verbs (forget, recall, remember, subscribe). No consistent pattern emerges, making tool names harder to predict and remember.

Tool Count2/5

At 34 tools, this server is heavy and tries to serve many unrelated domains—data research, prediction markets, package registries, memory, subscriptions, and AI visibility. The prediction-markets cluster alone accounts for six highly specialized tools that could be consolidated. The scope feels bloated rather than focused, which will overwhelm agents exploring the toolset.

Completeness4/5

Each domain within the server has solid coverage: data lookups offer stable, beta, grounded, and deep-research variants; entity analysis has profile, compare, changes, and resolve; subscriptions support create/list/delete/alert-read; memory has set/get/list/delete. Minor gaps exist (e.g., no direct package search by keyword, no tool to update a subscription), but the major workflows are covered and there are no dead ends.